The Efficacy of Cognitive Behavioral Therapy to Treat Depression and Anxiety and Improve Quality of Life Among Early-Stage Breast Cancer Patients

Integrative Cancer Therapies
Haoyao SunJinchang Wu

Abstract

Positive results have appeared among nonmetastatic breast cancer patients with the use of cognitive behavioral therapy (CBT). However, earlier stage patient results have been mixed. This novelty of this study was the focus on stage I and II breast cancer patients. The objective of the current study was to conduct a meta-analysis of psychosocial functions in early-stage breast cancer survivors to determine its efficacy. A search of Cochrane Library, EMBASE, MEDLINE, PsycInfo, and PubMed yielded 3237 abstracts, which were independently evaluated by research pairs. Meta-analysis was conducted on 8 studies that included a total of 1053 patients. Psychosocial functions were categorized according to 3 domains: (1) anxiety, (2) depression, and (3) quality of life. Improvement in anxiety was observed in patients treated with CBT relative to controls without CBT ( P = .04). Depression and quality of life improvement was not observed in the CBT group within or after 4 months of treatment ( P > .05). The results indicated that observed improvements in anxiety in patients with early-stage breast cancer were moderate. The effectiveness of CBT for the improvement of patient outcomes could not be determined, given the methodological and clini...Continue Reading

References

Mar 7, 2002·Cancer Practice·J S SimpsonM E Trew
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael F ScheierWilliam Scott Pappert
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annette L StantonThomas R Belin
Feb 24, 2007·Nature Reviews. Cancer·Tim A Ahles, Andrew J Saykin
May 9, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Janette VardyIan F Tannock
Nov 3, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J VardyS B Schagen
Dec 18, 2009·BMC Medicine·Tara DonkerHelen Christensen
Dec 19, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Nihal Bostanci Dastan, Sevim Buzlu
May 30, 2014·The Lancet Oncology·Lei FanPaul E Goss
Oct 8, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anja MehnertUwe Koch
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maja JohannsenRobert Zachariae
Aug 11, 2016·Psychotherapy and Psychosomatics·Susanne KuhntAnja Mehnert
Aug 19, 2016·Frontiers in Psychology·Debora AricòRaffaele Ferri
Feb 16, 2017·Behavior Modification·Shannon Sauer-ZavalaKatherine A Kennedy
Apr 5, 2017·Journal of the National Cancer Institute·Ahmedin JemalHannah K Weir

❮ Previous
Next ❯

Citations

Aug 11, 2020·Breast Cancer Research and Treatment·Kelly M TrevinoJun J Mao
Jun 17, 2020·Social Work in Health Care·Shehzad NiaziTeresa Rummans
Apr 4, 2021·Cancers·Saskia W M C MaassAnnette J Berendsen
Jul 20, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Faranak JelvehzadehHadi Ranjbar

❮ Previous
Next ❯

Methods Mentioned

BETA
cognitive behavioral therapy

Software Mentioned

Review Manager

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.